<ARTICLE> 5 <MULTIPLIER> 1,000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-END> SEP-30-1996 <CASH> 738,108 <SECURITIES> 128,324 <RECEIVABLES> 1,693,370 <ALLOWANCES> 77,017 <INVENTORY> 878,275 <CURRENT-ASSETS> 3,860,819 <PP&E> 7,007,920 <DEPRECIATION> 2,722,141 <TOTAL-ASSETS> 14,052,805 <CURRENT-LIABILITIES> 4,194,128 <BONDS> 2,582,340 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 355,564 <OTHER-SE> 5,671,087 <TOTAL-LIABILITY-AND-EQUITY> 14,052,805 <SALES> 5,016,934 <TOTAL-REVENUES> 5,285,524 <CGS> 1,330,610 <TOTAL-COSTS> 1,525,996 <OTHER-EXPENSES> 2,252,216<F1> <LOSS-PROVISION> 0<F2> <INTEREST-EXPENSE> 219,499 <INCOME-PRETAX> 1,548,518 <INCOME-TAX> 397,969 <INCOME-CONTINUING> 1,150,549 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1,150,549 <EPS-PRIMARY> 2.05 <EPS-DILUTED> 2.04 <FN> <F1>Note 1 - Amounts include research and development, selling and general and administrative expenses. <F2>Note 2 - The information called for is not given as the balances are not individually significant. </FN>